HEALTH TECHNOLOGY ASSESSMENT, PRICE AND REIMBURSEMENT REVIEW FOR ORPHAN DRUGS IN ITALY

被引：1
|
作者：
Tavella, F. [1 ]
Korchagina, D. [2 ]
Rodrigues, J. [2 ]
Remuzat, C. [2 ]
机构：
[1] Creativ Ceut, London, England
[2] Creativ Ceut, Paris, France
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1733
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY103
引用
收藏
页码：A540 / A540
页数：1
相关论文
共 50 条
  • [21] Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?
    Jommi, Claudio
    Addis, Antonio
    Martini, Nello
    Nicod, Elena
    Pani, Marcello
    Scopinaro, Annalisa
    Vogler, Sabine
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2021, 8 : 114 - 119
  • [22] THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE
    Nixon, F.
    VALUE IN HEALTH, 2008, 11 (06) : A375 - A376
  • [23] REIMBURSEMENT OF ORPHAN DRUGS: WHAT IS THE DIFFERENCE?
    Mueller, E.
    Schmidt, E.
    Ehreth, J.
    VALUE IN HEALTH, 2012, 15 (07) : A311 - A311
  • [24] PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA
    Kumar, J.
    Bachman, E. M.
    VALUE IN HEALTH, 2011, 14 (03) : A29 - A29
  • [25] REIMBURSEMENT AND PRICING OF ORPHAN DRUGS IN TAIWAN
    Cheng, C. Y.
    Chan, H. W.
    Fang, C. H.
    VALUE IN HEALTH, 2019, 22 : S856 - S856
  • [26] Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?
    Fontrier, Anna-Maria
    Kanavos, Panos
    VALUE IN HEALTH, 2023, 26 (07) : 1011 - 1021
  • [27] The implementation of health technology assessment principles in public decisions concerning orphan drugs
    Brenna, Elenka
    Polistena, Barbara
    Spandonaro, Federico
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (06) : 755 - 764
  • [28] ACCESS TO ORPHAN DRUGS IN POLAND - IS CHANGE IN HEALTH TECHNOLOGY ASSESSMENT APPROACH REQUIRED?
    Caban, A.
    Lach, S.
    Remuzat, C.
    Toumi, M.
    VALUE IN HEALTH, 2016, 19 (07) : A442 - A443
  • [29] INTERNATIONAL COMPARISONS OF HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT OUTCOMES FOR ONCOLOGY DRUGS WITH REGULATORY REVIEW THROUGH PROJECT ORBIS
    Beca, J.
    Scott, K.
    Gosselin, S.
    Ajrawat, P.
    Thon, J.
    Lee, S. M.
    VALUE IN HEALTH, 2023, 26 (06) : S238 - S238
  • [30] The implementation of health technology assessment principles in public decisions concerning orphan drugs
    Elenka Brenna
    Barbara Polistena
    Federico Spandonaro
    European Journal of Clinical Pharmacology, 2020, 76 : 755 - 764
12345